Review Article

Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective

Table 1

Animal models of NAFLD and NASH used to investigate the effect of herbal medicines.

Model (ingredients)DurationHerbal medicinePathological and biochemical changes; mechanisms involvedReference

Diet induced models (high calories/fats diet)

10% lard oil and 2% cholesterol4 wkSi Jun Zi Tang (SJZ), Lizhong Tang (LZ), Linggui Zhugan Tang (LGZG), and Shen Zhuo Tang (SZ)Reduced epididymal fat index and hepatic fats infiltration; reduced triglycerides and ALT levels.[84]

Methionine and choline bitartrate tablets4 wkAlkaloids of Rubus alceifoliusReduced hepatic lobule, serum ALT, AST, TNFα, and IL-6; hepatic SOD and MDA.[16]

25% lard, 2% cholesterol 0.5% sodium cholate, and 25% Tween-8056 dSchisandra chinensis BaillReduced SOD, serum TC, and LDLC and increased hepatic MDA. [85]

12% lard oil, 2% cholesterol, 0.2% propylthiouracil, and 0.5% bile salt 6 wkSapindus mukorossi Gaertn.Increased fat deposition, fat-storing cells proliferation, collagen accumulation, macrovesicular steatosis, ballooning degeneration, and cytoplasmic vacuolation (model group). Reduced liver cell volume, hepatic lobules, and fat droplets (treatment group). Reduced TC, TG, LDL-C, ALT, and AST; increased APN level in treatment group. [86]

10% lard, 2% cholesterol, 0.2% bile salts, 15% sucrose, 8% baking soybean powder 7 wkTZQ formula (red peony root, mulberry leaf, lotus leaf, danshen root, and hawthorn leaf)Increased hepatic steatosis, necrosis, and inflammatory cell infiltration (model group). Reduced TC, TG, LDL-C, HDL-C, and TC-HDL/HDL in treatment group. [87]

88% normal chow plus 10% lard plus 2% cholesterol4 wk + 4 wk treatmentJiang Zhi GranuleImproved hepatic steatosis, reduced ALT and AST, and improved free fatty acid and triacylglycerol levels. Reduced LXR alpha and SREBP-1c. [88]

MCD diet 8 wkFuzheng Huayu recipeModel group showed disoriented lobule, macrosteatosis, hepatocyte necrosis, and inflammatory infiltration. Treatment group reduced ALT, AST and P450 2E1, TNFα, and IL-6. Increased HO-1. Inhibited alpha-SMA, TGF-β1, and Col I and Col III. [17]

High fat diet8 wkPing-tang recipeSuppressed visceral fat accumulation, enhanced glucose metabolism, and ameliorated hepatic steatosis. Upregulated PGC-1 alpha, PPAR alpha, and gamma and reduced SREBP-1c, FAS, and FABP; activated AMPK and acetyl CoA carboxylase phosphorylation.[25]

High fat and high fructose diet9 wkPuerariae radix, Lycium barbarum, Crataegus pinnatifida, and Polygonati rhizomaReduced fasting blood glucose and improved insulin resistance. [89]

10% lard, 1.5% cholesterol, 0.2% sodium deoxycholate, 5% sugar, 0.05% prothiopyrimidine10 wk (5 wk treatment)Yiqi huoxue decoction and solutions of herbsHepatic fat deposit, macrovesicular steatosis, ballooning degeneration, and cytoplasmic vacuolation (model group); reduced lipid degeneration, fat droplets and smaller liver cells, and delineated hepatic lobules (treatment group). [90]

9.3 g AIN-93MX, 2.6 g AIN-93VX, 0.5 g choline bitartrate, 1.1 g DL-methionine, 57.5 g lactalbumin hydrolysate, 117.5 g dextrose, 36.6 mL fish oil, and 4.5 g suspending agent K 12 wkLycium barbarum polysaccharidesReduced lipid droplet accumulation, inflammatory cells infiltration, and hepatocyte necrosis as observed in model group. Reduced phosphorylation of TGF-β1 and α-SMA. Decreased SREBP-1c and PPARγ2, but reduced ATGL and adiponectin; restored antioxidant enzymes; reduced NF-κB, p-p38 MAPK, and enhanced autophagy.[15]

High fat diet12 wkChinese medicine recipesTreatment group blocked fatty degeneration. Decreased expressions of JNK and p-JNK. [91]

5.3 kcal/g (fat 59%, protein 16%, and carbohydrate 24%)15 wkYin-Chen-Hao-TangReduced hepatocyte foaming and ballooning. Reduced TNF-α and MCP-1. Promoted senescence marker protein-30 metabolism. Restored oxidative stress markers.[92]

45 kcal% fat, 20 kcal% protein, and 35 kcal% carbohydrate16 wkGarcinia cambogia supplementIncreased collagen deposition in treatment group. Reduced obesity, but induced hepatic fibrosis (inflammation TNF-α and MCP-1 and oxidative stress SOD, GSH-Px, and TBARS increased).[93]

Axungia porci 10%, cholesterol 1.5%, and bile salt 0.5% 16 wkChaihu-Shugan-San and Shen-ling-bai-zhu-SanModel group showed microvesicular and macrovesicular steatosis, lobular, and portal inflammation and hepatocyte ballooning while treatment group improved them. Decreased TNF-alpha and IL-6 in serum, inhibited TLR4, and activation of p38 MAPK.[94]

High fat diet16 wkSoothing liver and invigorating spleen recipesReduced TC, LDL-C, TC, and TG in treatment group. Reduced TLR4 expression. [95]

21.9 kJ/g, 60% fat, 20% protein, and 20% carbohydrate20 wkTroxerutinDecreased epididymal adipose tissue mass, lipid accumulation, and lipid levels in treatment group. Suppressed NAD (+) depletion, increased NAMPT, and decreased PARP1. Increased SirT1 and AMPK and inhibited mTORC1 and Lpin 1β/α.[96]

60% of kcal as fat with an energy density of 5.24 kcal/g24 wkCrude extract of Lycium barbarum polysaccharideLowered TC, LDL, TG, and DAG levels. Induced phosphorylation of AMPK, reduced nuclear expression of SREBP-1c, and increased UCP1 and PGC-1 alpha in adipose tissue.[62]

60% kcal from lard/soybean 9.8 : 14 mo + 40 d treatmentRheinSteatotic and enlarged hepatocytes (model group); reduced lipid accumulation (treatment group). Reduced ALT, TC, LDL, and TG level in treatment group and improved insulin resistant. Suppressed SREBP-1c and LXR; inhibited T-BET, and enhanced GATA-3 and pSTAT3. [14]

15% fat, 15% sucrose, and 2% cholesterol12 wkSalvia-Nelumbinis naturalisReduced macrovesicular steatosis, TG, LDL-C, and FFA levels. Increased IRS and Akt phosphorylation and decreased SOCS3.[97]

High fat dietCigu Xiaozhi pillsModel group showed adipose degeneration and inflammatory cell infiltration. Treatment group reduced TG, TC, ALT, AST, and MDA level while increased SOD and GPX. Reduced TNFα.[98]

Models developed by combined insults

ApoE (−/−) + high cholesterol diet4 wkHuanglian Jiedu decoctionAmeliorated pathological changes in fatty liver. Associated with increase of M2 macrophages populations.[20]

MCD diet in db/db mice4 wkSho-saiko-to (TJ-9), inchin-ko-to (TJ-135), juzen-taiho-to (TJ-48), and keishi-bukuryo-gan (TJ-25)TJ-9 and TJ-48 reduced ALT. Necroinflammation, hepatic lobules, steatosis, and ballooning degeneration. Reduced TGF-β1, increased TNFα, IL-6, and PPAR-gamma, and reduced MDA.[21]

High fat diet  + streptozotocin i.p.4 wkpomegranate flowers polyphenolsReduced fat drops, non-HDL-C, and transaminase. Antioxidant ability enhanced and PON1 increased in liver.[19]

High fat diet (10% lard and 2% cholesterol) + CCl48 wkDangyao (Swertia pseudochinensis Hara) and Shuifeiji (Silybum marianum Gaertn.)Ameliorated hepatosteatosis lobules ballooning degeneration and inflammatory infiltration as observed in model group. Reduced ALT, AST, TAG, and MDA. Increased UCP2.[18]

High fat diet (88% normal chow + 10% lard + 2% cholesterol) + CCl48 wkDangfei Liganning capsulesImproved steatosis, hepatocyte ballooning, and inflammatory infiltration as observed in model group. Improved MDA and ALT. [99]

10% lard + 2% cholesterol + CCl48 wkSoothing liver and invigorating spleen recipesReduced SREBP-1 and SCD-1.[100]

High cholesterol diet in KK-Ay mice10 wkCorosolic acidReduced blood cholesterol and liver cholesterol content. Inhibited activity of cholesterol acyltransferase.[101]

High fat diet (640 kcal/100 g) + gold-thioglucose12 wkBofutsushosanBlocked hepatic steatosis, inflammation, hepatocyte ballooning, and Mallory-Denk bodies. Reduced ALT, AST, and TG levels. Induced adiponectin and its receptors, increased PPAR-α and PPAR-γ, and decreased SREBP-1c; reduced IR by phosphorylated Akt.[24]

HF diet (19.6% carbohydrates, 18.2% proteins, and 62.2% lipids; total energy, 506 kcal/100) and 30% sucrose in drinks 12 wkGoshajinkiganReduced AST. Increased body and adipose tissue weight and reduced elevated liver weight. [102]

Content not specified in the paper.